Updates are available Correction dated 2021-01-19
Click to view Correction: https://doi.org/10.1186/s13287-020-02077-9
-
Authors
Filice, Dominic
Dhahri, Wahiba
Solan, Joell L.
Lampe, Paul D.
Steele, Erin
Milani, Nikita
Van Biber, Benjamin
Zhu, Wei-Zhong
Valdman, Tamilla Sadikov
Romagnuolo, Rocco
Otero-Cruz, José David
Hauch, Kip D.
Kay, Matthew W.
Sarvazyan, Narine
Laflamme, Michael A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P01-HL094374)
National Institutes of Health (RO1-HL117991, RO1-GM055632, R21-HL122882)
McEwen Stem Cell Institute
Peter Munk Cardiac Centre
John R. Evans Leaders Fund/Canadian Foundation for Innovation
Canada First Research Excellence Fund
- License Information
-
More Information
Article History
Received: 21 May 2020
Accepted: 1 September 2020
First Online: 25 September 2020
Change Date: 19 January 2021
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: All hESC experiments were conducted with the approval of either the University of Washington ESC Research Oversight Committee or the Canadian Institutes of Health Research (CIHR) Stem Cell Oversight Committee (SCOC). All animal procedures were conducted with the approval of the local institutional animal care committees of either the University of Washington or University Health Network (Toronto) in compliance with corresponding national guidelines.
: Not applicable.
: MAL is a founding investigator and consultant for BlueRock Therapeutics.
